AcelRx Pharma Plunges After FDA Rejects Device
AcelRx Pharmaceuticals (ACRX) stock plunged more than 40% below 7 in afternoon trading on the stock market today after the FDA rejected the specialty-drug startup’s drug-dispensing device late Friday. The product in question is Zalviso, a device designed to let hospital patients self-dispense doses of the oral painkiller sufentanil, partly with components supplied by Mallinckrodt (MNK) and Patheon. The FDA’s letter to the company expressed concern